Showing results (21-30 of 159) with videos related to
Sort By:
Pageof 16
The Journal of General Virology|April 11, 2006
In vivo antiviral activity: defective interfering virus protects better against virulent Influenza A virus than avirulent virusNigel J Dimmock, Anthony C MarriottFEBS Letters|May 16, 1994
Tamoxifen decreases drug efflux from liposomes: relevance to its ability to reverse multidrug resistance in cancer cells?R Kayyali, C Marriott, H WisemanReviews in Medical Virology|December 31, 2009
Defective interfering viruses and their potential as antiviral agentsA C Marriott, N J DimmockThe Journal of Pharmacy and Pharmacology|August 10, 2000
A human oral-throat cast integrated with a twin-stage impinger for evaluation of dry powder inhalersT Srichana, G P Martin, C MarriottThe Journal of Pharmacy and Pharmacology|December 1, 1988
Effects of phosphatidylcholine on the topical bioavailability of corticosteroids assessed by the human skin blanching assayM Jacobs, G P Martin, C MarriottThorax|September 1, 1988
Binding and diffusion characteristics of 14C EDTA and 99mTc DTPA in respiratory tract mucus glycoprotein from patients with chronic bronchitisM S Cheema, S Groth, C MarriottJournal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|December 9, 1993
Potential use of microencapsulation for sustained drug delivery to the respiratory tractM Haghpanah, C Marriott, G P MartinEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitroT Srichana, G P Martin, C MarriottJournal of Pharmaceutical and Biomedical Analysis|November 11, 2005
Validation of a reverse-phase high performance liquid chromatographic method for concurrent assay of a weak base (salmeterol xinafoate) and a pharmacologically active steroid (fluticasone propionate)D Murnane, G P Martin, C MarriottCurrent Topics in Medicinal Chemistry|February 22, 2008
Recent advances in the development of selective ligands for the cannabinoid CB(2) receptorKarla-Sue C Marriott, John W HuffmanPageof 16